SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories informs about newspaper publication

05 Nov 2020 Evaluate

Pursuant to Regulation 30 & 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Coral Laboratories has informed that it has enclosed copies of Notice of Board Meeting to be held on 12th November, 2020 to consider and approve unaudited financial results of the quarter and half year ended 30th September, 2020 published in following newspapers: Business Standard(English), Western Times (Gujrati), and Western Times (English) all dated on 05.11.2020.

The above information is a part of company’s filings submitted to BSE.


Coral Laboratories Share Price

420.00 -1.20 (-0.28%)
22-Apr-2026 11:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.30
Dr. Reddys Lab 1219.90
Cipla 1230.95
Zydus Lifesciences 931.80
Lupin 2313.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×